谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Supplementary Table S2 from Efficacy and Safety of Adagrasib plus Cetuximab in Patients with KRASG12C-Mutated Metastatic Colorectal Cancer

Rona Yaeger,Nataliya V. Uboha,Meredith S. Pelster,Tanios S. Bekaii-Saab,Minal Barve,Joel Saltzman,Joshua K. Sabari,Julio A. Peguero,Andrew Scott Paulson,Pasi A. Jänne,Marcia Cruz-Correa,Kenna Anderes,Karen Velastegui,Xiaohong Yan,Hirak Der-Torossian, Samuel J. Klempner,Scott E. Kopetz

crossref（2024）

引用 0|浏览17
暂无评分
摘要
Table S2. Demographics and baseline characteristics of patients with KRASG12C-mutated unresectable or metastatic CRC receiving adagrasib monotherapy.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要